4.7 Article

The global burden of heterogeneity of lupus erythematosus interventional trials

Related references

Note: Only part of the references are listed.
Review Rheumatology

Update on the diagnosis and management of systemic lupus erythematosus

Antonis Fanouriakis et al.

Summary: Systemic lupus erythematosus (SLE) is characterized by clinical heterogeneity, unpredictable course and flares. Diagnosis remains clinical with limited serologic test confirmation, and newer classification criteria offer more accurate classification. Treatment goals focus on patient survival, flare prevention, organ damage prevention, and quality of life optimization. High-intensity immunosuppressive therapy followed by less intensive therapy is typically used to control disease activity in severe cases of SLE.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Review Urology & Nephrology

How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not

Teun van Gelder

Summary: CNIs and mycophenolate are commonly used in the treatment of kidney transplant recipients and glomerular diseases, with cyclosporine potentially causing a drug-drug interaction that affects mycophenolate metabolism. Clinicians should be cautious in adjusting drug dosages when using cyclosporine in combination with mycophenolate.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Update on Lupus Nephritis: Core Curriculum 2020

Samir Parikh et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Review Immunology

Autoimmunity and organ damage in systemic lupus erythematosus

George C. Tsokos

NATURE IMMUNOLOGY (2020)

Review Rheumatology

Epidemiology of systemic lupus erythematosus: an update

George Stojan et al.

CURRENT OPINION IN RHEUMATOLOGY (2018)

Review Allergy

Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Jyoti Bakshi et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)

Article Medicine, General & Internal

Broad Concepts in Management of Systemic Lupus Erythematosus

Vaidehi R. Chowdhary

MAYO CLINIC PROCEEDINGS (2017)

Review Rheumatology

Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment

Fulvia Ceccarelli et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)

Review Rheumatology

The global burden of SLE: prevalence, health disparities and socioeconomic impact

Erin E. Carter et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Article Medicine, General & Internal

Systemic lupus erythematosus

Larissa Lisnevskaia et al.

LANCET (2014)

Review Rheumatology

Global trends, potential mechanisms and early detection of organ damage in SLE

Anselm Mak et al.

NATURE REVIEWS RHEUMATOLOGY (2013)

Review Immunology

Lupus nephritis: A critical review

Andrea T. Borchers et al.

AUTOIMMUNITY REVIEWS (2012)

Article Biotechnology & Applied Microbiology

The discovery and development of belimumab: the anti-BLyS-lupus connection

William Stohl et al.

NATURE BIOTECHNOLOGY (2012)

Article Medicine, General & Internal

Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study

Andrew P. Prayle et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Article Health Care Sciences & Services

Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry

Jaime L. Peters et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)

Article Mathematical & Computational Biology

Quantifying heterogeneity in a meta-analysis

JPT Higgins et al.

STATISTICS IN MEDICINE (2002)